BRAF and colorectal carcinoma: Functional screening revealed that knockout of PHGDH, PSAT1, SLC1A5 and SLC38A2 significantly impaired the survival of CRC cell lines, including those harbouring TP53, KRAS or BRAF mutations (Figure S12A–D).